Compartir
Información de la revista
Contenido especial sobre el coronavirus SARS-CoV-2 (COVID-19) en Vacunas
Optic neuritis associated with COVID-19-related vaccines
Masoud Keikha, Mehdi Zandhaghighi, Shahram Shahraki Zahedani
10.1016/j.vacun.2022.12.002
Vacunas. 2023;24:158-9
Vacunación frente a la COVID-19 a partir de los 6 meses de edad. Completando el círculo de la prevención en pediatría
Fernando Moraga-Llop
10.1016/j.vacun.2022.12.004
Vacunas. 2023;24:84-7
Evaluating the characteristics of patients with SARS-CoV-2 infection admitted during COVID-19 peaks: A single-center study
Seyede Faezeh Mousavi, Mohammadamin Ebrahimi, Seyed Amirhosein Ahmadpour Moghaddam, Narges Moafi, Mahbobe Jafari, Ayoub Tavakolian, Mohsen Heidary
10.1016/j.vacun.2022.08.002
Vacunas. 2023;24:27-36
Parents' perception of COVID-19 risk of infection and intention to vaccinate their children
Hamdy Khaled Sabra, Mostafa Abdulraheem Bakr, Omar El Sayed Mohmed Rageh, Asmaa Khaled, Omnia Mohamed Elbakliesh, Ibrahim Ali Kabbash
10.1016/j.vacun.2022.07.004
Vacunas. 2023;24:37-44
Vaccine hesitancy and the challenge of controlling COVID-19 and other vaccine-preventable diseases
Paulo Ricardo Martins-Filho
10.1016/j.vacun.2022.08.004
Vacunas. 2023;24:74-5
Multivalent vaccines against new SARS-CoV-2 hybrid variants
Kiarash Ghazvini, Masoud Keikha
10.1016/j.vacun.2022.06.002
Vacunas. 2023;24:76-7
Determination of binding affinity of tunicamycin with SARS-CoV-2 proteins: Proteinase, protease, nsp2, nsp9, ORF3a, ORF7a, ORF8, ORF9b, envelope and RBD of spike glycoprotein
Ali Adel Dawood
10.1016/j.vacun.2022.10.006
Vacunas. 2023;24:1-12
The significant role of Carbapenems-resistant Acinetobacter Baumannii in mortality rate of patients with COVID-19
Ali AliMohammadi, Nahid Chezani-sharahi, Zahra Asgari Hezaveh, Elnaz Abbasi, Aref Shariati, Ehsanollah Ghaznavi-Rad
10.1016/j.vacun.2022.10.004
Vacunas. 2023;24:13-8
IR-7883. Inmunogenicidad de una vacuna de proteína recombinante contra el SARS-CoV-2 (PHH-1V) como primovacunación en adultos sanos en Vietnam
Fumana, C. Garriga Alsina, L. Ferrer Soler, E. Torroella Busquets
10.1016/j.vacun.2022.09.043
Vacunas. 2022;23 Supl 3:25-6
IR-7641. Cobertura vacunal antineumocócica en pacientes mayores de 65 años hospitalizados por la enfermedad de SARS-CoV-2
Diez, Hernandez, V. Fernández Espinilla, Simon, Garcia, J.J. Castrodeza Sanz
10.1016/j.vacun.2022.09.042
Vacunas. 2022;23 Supl 3:25